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Conclusions
The role of drug allergy in the etiology of any case of any of the 'collagen diseases' is far from having been established. However, the possibility that such cases occur cannot be dismissed simply because clear-cut, scientifically acceptable evidence of a cause-and-effect relationship between the administration of a drug and the development of the manifestations of the disease is lacking. REFERENCES Meyler L (1960) The fact that certain chemicals are able to bring about the lysis of red cells in vivo in laboratory animals has been known since before the end of the last century and, similarly, acute hemolytic anemia has been reported from time to time in man as a consequence of the accidental or suicidal ingestion or inhalation of a wide range of chemicals. Sodium chlorate, arsine, methyl chloride, naphthalene, trinitrotoluene and nitrobenzene are examples. However, it is only comparatively recently that hmmolytic animia due to chemicals or drugs used therapeutically has been widely recognized as a not very rare and sometimes extremely dangerous complication of orthodox medical treatment. It was in fact the introduction of sulphanilamide and its analogues in the late 1930s which put drug-induced hemolytic anemia in the forefront of medical literature. The size of this particular problem can be gauged by the fact that, following the first report of Harvey & Janeway (1937 ), Wood (1938 reported that of 522 patients treated with sulphanilamide 8 3 % of the children and 2-4% of the adults developed acute himolytic anemia; this report came from the Johns Hopkins Hospital, Baltimore, and most of the patients were negroes. This type of hemolytic anemia is fortunately now a rarity, for the sulphonamide drugs now in use seem to bring about himolysis far less readily than did sulphanilamide itself, which is no longer used.
One of the curious features of sulphanilkmide hemolytic aniemia, which was remarked upon at the time of its occurrence, was its capriciousness. While it was realized that a slight degree of progressive anemia commonly occurred in patients taking the drug continuously, it was equally clear that some patients taking relatively small doses for short periods of timeeven for only twentyfour to seventy-two hoursoccasionally developed heamolysis of catastrophic severity. On the other hand, drugs such as glucosulfone (once used in the treatment of leprosy) were known which regularly caused progressive hemolysis in all patients, so much so that a significant degree of anemia was to be expected after eight to ten days' treatment at the usual dosage (Hall et al. 1942). These discrepancies between the way in which different drugs acted led to the concept of two types of drug-induced hemolytic anxmia. First, a type of regular occurrence and secondly, atype where the idiosyncrasy or hypersensitivity of an individual patient appeared to play an all-important role. In this brief review, I shall set out the facts as they are known to-day, with particular reference to the mechanisms of this apparent idiosyncrasy or hypersensitivity. The drugs which cause hkmolytic anaemia make a long list, the most important of which are shown in Table 1 .
I should like to stress that all these drugs given in sufficient dosage for long enough probably exert a harmful effect on the red cells. This is as true of widely used drugs such as phenacetin as it is of acetylphenylhydrazine which, although largely superseded now in the treatment of polycythmmia, was at one time extensively used. However, it is also true, as I have already indicated, that some of these drugs act much more There are three main signs by which a hematologist recognizes a drug-induced hmmolytic anmmia: (1) A rather characteristic irregularity in shape of some of the red cells; often the cells are contracted and appear as if bits had been eaten out of them -I refer to these as irregularlycontracted cells. Coarse punctate basophilia may or may not be associated.
(2) Methemoglobin and/or sulphwmoglobin formation. (3) The presence of Heinz bodies.
These changes may or may not occur simultaneously, but the presence of any or all of them should make one suspect a drug-induced hemolytic anemia. The recognition of such changes, particularly when they are not too obvious, is of more than academic interest: not so very infrequently the puzzle of an obscure anemia may be solved by a glance down the microscope in a case where a drug etiology has not been considered. This can arise because the patient has been taking a drug in what is generally (but erroneously) considered to be a normal and harmless dosage, or because the patient is hypersensitive to a commonly used and usually benign drug, or because a patient has secretly been taking a potentially hemolytic drug unbeknown to his doctor. Fig 1 illustrates the subtle changes which may be produced by a drug taken in conventional dosage. The film is from a patient who had been taking for the previous two months 2-3 sleeping tablets each nightthe recommended dose. Each tablet, however, contained 3j gr of phenacetin. The patient was admitted to hospital after two Fig 1 Blood film from a patient suffering from a hamo-Jytic ana?mia probably due to phenacetin. The irregularly contracted red cells towards the centre of the field are characteristic ofdrug-induced hamolysis months of this regime with a hmemoglobin of 8-4 g/100 ml (57 %). She rapidly recovered when taken off the offending drug. Her red cells were later shown to be normal.
Idiosyncrasy and Hypersensitivity Mechanisms
There are in fact two such mechanisms. The first, historically speaking, and the commonest, is the idiosyncrasy brought about by the possession of 'enzyme-deficient' red cells. The enzyme which is deficient is glucose-6-phosphate dehydrogenase. This enzyme plays a vital part in normal red-cell metabolism for it acts in the 'shunt' mechanism as a hydrogen donor to TPN (triphosphopyridine nucleotide). The reduced form of TPN, TPNH, is a co-enzyme for the reduction by glutathione reductase of the oxidized form of glutathione to reduced glutathione. This step is thought to be essential for many intracellular processes including the metabolic degradation of drugs. The absence or severe deficiency of glucose-6-phosphate dehydrogenase leads to the cells being unable to stand the stress of drugs which act as powerful oxidizing agents.
The discovery of enzyme-deficient red cells stems from the brilliant work of Dern, Weinstein, Alving and Beutler and their colleagues in the United States who first, in 1953, and subsequently in a whole series of papers (see Weinstein et al. 1953 , Beutler 1959 , established that the sensitivity of negroes to the antimalarial drug, primaquine, was due to an inherited red-cell enzyme defect. One manifestation of this is socalled glutathione instability and this can be used as a test for the defect. Glutathione instability refers to a marked lowering ofreduced glutathione when red cells are exposed to acetylphenylhydrazine in vitro. Later the basic abnormality was pinned down (Carson et al. 1956 ) as a deficiency of the enzyme glucose-6-phosphate dehydrogenase.
The literature on glucose-6-phosphate dehydrogenase deficiency is by now a large one and deficiency of the enzyme is now known to affect not only the negro race, but Sephardic Jews and certain Mediterranean peoples also. The deficiency not only makes the bearer unusually susceptible to hmmolysis by the aminoquinolines, of which primaquine is the prototypein doses which do not affect normal peoplebut it also causes susceptibility to a wide range of other drugs, the most important of which are (or were) sulphanilamide (which explains the high incidence of hoemolytic anemia due to this drug in negroes), phenacetin, phenylhydrazine, sulfoxone, thiazosulphone, sulphacetamide and naphthalene. The discovery of enzyme-deficient red cells has thus provided an explanation for unusual susceptibility to a wide range of drugs and chemicals. It has also demonstrated that an apparently acquired disease may be based fundamentally on a congenital defect as well as incidentally starting off a new chapter in human genetics.
The second way in which drug sensitivity hemolytic antemia can be produced, which is much rarer, is based on an auto-immune mechanism, and can be looked upon as an example of true hypersensitivity. Its recognition stems from the observations of Harris (1954 Harris ( , 1956 in America on a patient who was treated for schistosomiasis with an antimony-containing drug. The patient had received a course of the drug ten years before without apparent incident, but when the second course was started he developed signs of intolerance by the fifth day and was found to be anmmic and to have developed hemoglobinuria. He had in fact hemolytic anmmia and the direct antiglobulin test was positive. Harris was subsequently able to show that the patient had developed an antibody which acted on his red cells, and normal red cells also, but only in the presence of the drug. It seems likely that the patient had formed an antibody against a drugred-cell complex and that this then reacted against the patient's own red cells in vivo, presumably being bound to the cells through the intermediacy of the drug. Since Harris's pioneer studies, a similar mechanism has been demonstrated in the case of quinidine (Freedman et al. 1956 ), quinine (Muirhead et al. 1958), phenacetin and PAS (MacGibbon et al. 1960 ), antazoline (Dausset & Bergerot-Blondel 1961 , Mallassenet et al. 1960 , and salicylazosulphapyridine (Shinton & Wilson 1960) .
We have investigated two of these cases at the Postgraduate Medical School of London; in one patient phenacetin was involved, in the other PAS. The history of the patient who was hypersensitive to phenacetin is of exceptional interest:
Case report A woman, aged 38, was admitted to hospital in April 1958 suffering from jaundice and oliguria of unknown origin. Severe oliguria and azotemia persisted but diuresis commenced on the tenth day and she made a good recovery. In October 1958, six months later, she became seriously ill once more after taking four analgesic tablets for incipient coryza, again with jaundice and oliguria. This time she was admitted into Hammersmith Hospital where she once more recovered on conservative treatment. The tablets she had taken were found to contain phenacetin and this led to a series of serological investigations the result of which paralleled those reported by Harris. In particular, her serum sensitized normal red cells to agglutination by antiglobulin serum in the presence of phenacetin at a concentration of 2-5 ,ig/100 ml upwards. Two known metabolic products of phenacetin, paracetamol and paraphenetidine, also produced positive reactions.
Phenacetin may have many virtues, but it is without doubt remarkable in being capable of producing hxemolytic anemia in three ways: (1) In normal therapeutic dosage in apparently normal (not enzyme-deficient) subjects, (2) in (presumably) very small dosage in enzyme-deficient subjects, and (3) in rare instances, as described above, by an auto-immune mechanism.
In summary, it is obvious that the drug-induced hemolytic anemias are still important clinical problems and that they are likely to remain so as long as new drugs are invented. The discovery of enzyme deficiency of red cellswhich can be demonstrated in the laboratory by comparatively simple techniqueshas provided an explanation for a type of racial susceptibility to drugs. Knowledge of the possibility of this deficiency should put the physician on his guard when treating members of the negro and Jewish races, in particular. Haemolysis resulting from the immune mechanism of hypersensitivity is much rarer, but it is of more than laboratory interest only, for in individual patients it can lead to a serious catastrophe.
